On This Page
Meningococcal vaccines routinely used in the United States protect against most types of meningococcal disease, but they do not prevent all cases. There are two kinds of vaccines against Neisseria meningitidis bacteria available in the United States: meningococcal polysaccharide vaccine (Menomune®) and meningococcal conjugate vaccine (Menactra®, Menveo® and MenHibrix®).
For more information on meningococcal vaccines and who should receive them, visit the Meningococcal Vaccine site or Recommendations of the Advisory Committee on Immunization Practices.
What You Need to Know about the Meningococcal Vaccine
- Meningococcal Vaccine Basics
Offers comprehensive information about meningococcal vaccines and other educational tools.
- Who Should Get the Vaccine
- Who Should Not Get the Vaccine
- Possible Reactions to Vaccination
- Vaccine Safety
Meningococcal Vaccine Resources for Health Care Professionals
The National Immunization Survey (NIS) is a large, on-going survey of immunization coverage among US pre-school children (19-35 months of age). In conjunction with the NIS, CDC also conducts the NIS-Teen (13 to 17 years of age) and the NIS-Adult.
Images and logos on this website which are trademarked/copyrighted or used with permission of the trademark/copyright or logo holder are not in the public domain. These images and logos have been licensed for or used with permission in the materials provided on this website. The materials in the form presented on this website may be used without seeking further permission. Any other use of trademarked/copyrighted images or logos requires permission from the trademark/copyright holder...more
This graphic notice means that you are leaving an HHS Web site. For more information, please see the Exit Notification and Disclaimer policy.